| HOME >> BIOLOGY >> TECHNOLOGY |
Retained earnings 25,206,169 12,386,636
Total Stockholders' Equity 39,761,358 20,850,209
TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY $43,706,320 $28,514,381
CHINA PHARMA HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME
For the years
ended December 31,
2007 2006
Revenue $33,186,324 $21,843,262
Cost of revenue 17,619,180 11,745,815
Gross profit 15,567,144 10,097,447
Operating expenses:
Selling expenses 1,436,609 260,128
General and administrative 1,879,306 1,213,828
Total operating expenses 3,315,915 1,473,956
Income from operations 12,251,229 8,623,491
Non-operating income
(expenses):
Interest income 31,805 991
Interest expense (237,398) (145,881)
Other income 611,025 108,485
Total non-operating income
(expense) 405,432 (36,405)
Income before taxes 12,656,661 8,587,086
Income tax benefit 162,872 --
Net income $12,819,533 $8,587,086
Comprehensive income - foreign
currency
'/>"/>
| SOURCE China Pharma Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |